Trends in Cardiovascular Medicine
Volume 16, Issue 1 , Pages 29-34 , January 2006

Defective Lung Vascular Development in Endothelial Nitric Oxide Synthase-Deficient Mice

  • Robin N.N. Han
    • ,
  • Duncan J. Stewart

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Duncan J. Stewart, Division of Cardiology, McLaughlin Center for Molecular Medicine, University of Toronto, St Michael's Hospital, Suite 6050 Queen's Wing, 30 Bond Street, Toronto, Canada. Tel.: (+1) 416-864-5724; fax: (+1) 416-864-5914.

References 

  1. Abman SH. Bronchopulmonary dysplasia: “A vascular hypothesis”. Am J Respir Crit Care Med. 2001;164:1755–1756
  2. Aicher A, Heeschen C, Mildner-Rihm C, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med. 2003;9:1370–1376
  3. Akeson AL, Wetzel B, Thompson FY, et al. Embryonic vasculogenesis by endothelial precursor cells derived from lung mesenchyme. Dev Dyn. 2000;217:11–23
  4. Babaei S, Teichert-Kuliszewska K, Monge JC, Mohamed F, et al. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ Res. 1998;82:1007–1015
  5. Babaei S, Teichert-Kuliszewska K, Zhang Q, Jones N, et al. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am J Pathol. 2003;162:1927–1936
  6. Balasubramaniam V, Tang JR, Maxey A, Plopper CG, et al. Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse. Am J Physiol Lung Cell Mol Physiol. 2003;284:L964–L971
  7. Colen KL, Crisera CA, Rose MI, Connelly PR, et al. Vascular development in the mouse embryonic pancreas and lung. J Pediatr Surg. 1999;34:781–785
  8. Compernolle V, Brusselmans K, Acker T, et al. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med. 2002;8:702–710
  9. Cooke JP. NO and angiogenesis. Atheroscler Suppl. 2003;4:53–60
  10. DeMello DE. Pulmonary pathology. Semin Neonatol. 2004;9:311–329
  11. DeMello DE, Reid LM. Embryonic and early fetal development of human lung vasculature and its functional implications. Pediatr Dev Pathol. 2000;3:439–449
  12. DeMello DE, Sawyer D, Galvin N, Reid LM. Early fetal development of lung vasculature. Am J Respir Cell Mol Biol. 1997;16:568–581
  13. Dulak J, Jozkowicz A. Regulation of vascular endothelial growth factor synthesis by nitric oxide: Facts and controversies. Antioxid Redox Signal. 2003;5:123–132
  14. Dulak J, Jozkowicz A, Dembinska-Kiec A, et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2000;20:659–666
  15. Feng Q, Song W, Lu X, Hamilton JA, et al. Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation. 2002;106:873–879
  16. Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439–442
  17. Fukumura D, Gohongi T, Kadambi A, Izumi Y, et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A. 2001;98:2604–2609
  18. Galambos C, Ng YS, Ali A, Noguchi A, et al. Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms. Am J Respir Cell Mol Biol. 2002;27:194–203
  19. Gregg AR, Schauer A, Shi O, Liu Z, et al. Limb reduction defects in endothelial nitric oxide synthase-deficient mice. Am J Physiol. 1998;275:H2319–H2324
  20. Hall SM, Hislop AA, Pierce CM, Haworth SG, et al. Prenatal origins of human intrapulmonary arteries: Formation and smooth muscle maturation. Am J Respir Cell Mol Biol. 2000;23:194–203
  21. Hall SM, Hislop AA, Haworth SG. Origin, differentiation, and maturation of human pulmonary veins. Am J Respir Cell Mol Biol. 2002;26:333–340
  22. Han RN, Post M, Tanswell AK, Lye SJ. Insulin-like growth factor-I receptor-mediated vasculogenesis/angiogenesis in human lung development. Am J Respir Cell Mol Biol. 2003;28:159–169
  23. Han RN, Babaei S, Robb M, Lee T, et al. Defective lung vascular development and fatal respiratory distress in endothelial NO synthase-deficient mice: A model of alveolar capillary dysplasia?. Circ Res. 2004;94:1115–1123
  24. Han RN, Slevin J, Sunn N, Adamson L, et al. Feasibility of fetal transplantation of endothelial progenitor cells for the rescue of lethal respiratory distress in eNOS-deficient mice. Can J Cardiol. 2005;21(Suppl C):175C
  25. Isenberg JS. Nitric oxide modulation of early angiogenesis. Microsurgery. 2004;24:385
  26. Jakkula M, Le Cras TD, Gebb S, Hirth KP, et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol. 2000;279:L600–L607
  27. Josko J, Mazurek M. Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med Sci Monit. 2004;10:RA89–RA98
  28. Lee TC, Zhao YD, Courtman DW, Stewart DJ. Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation. 2000;101:2345–2348
  29. Leuwerke SM, Kaza AK, Tribble CG, Kron IL, et al. Inhibition of compensatory lung growth in endothelial nitric oxide synthase-deficient mice. Am J Physiol Lung Cell Mol Physiol. 2002;282:L1272–L1278
  30. Li H, Wallerath T, Forstermann U. Physiological mechanisms regulating the expression of endothelial-type NO synthase. Nitric Oxide. 2002;7:132–147
  31. Maeda S, Suzuki S, Suzuki T, Endo M, et al. Analysis of intrapulmonary vessels and epithelial–endothelial interactions in the human developing lung. Lab Invest. 2002;82:293–301
  32. Moncada S, Palmer RM, Higgs EA. The biological significance of nitric oxide formation from l-arginine. Biochem Soc Trans. 1989;17:642–644
  33. Murohara T, Asahara T, Silver M, Bauters C, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101:2567–2578
  34. North AJ, Star RA, Brannon TS, Ujiie K, et al. Nitric oxide synthase type I and type III gene expression are developmentally regulated in rat lung. Am J Physiol. 1994;266:L635–L641
  35. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967;276:357–368
  36. Parera MC, Van Dooren M, Van Kempen M, de Krijger R, et al. Distal angiogenesis: A new concept for lung vascular morphogenesis. Am J Physiol Lung Cell Mol Physiol. 2005;288:L141–L149
  37. Parker TA, Le Cras TD, Kinsella JP, Abman SH. Developmental changes in endothelial nitric oxide synthase expression and activity in ovine fetal lung. Am J Physiol Lung Cell Mol Physiol. 2000;278:L202–L208
  38. Pauling MH, Vu TH. Mechanisms and regulation of lung vascular development. Curr Top Dev Biol. 2004;64:73–99
  39. Saura M, Zaragoza C, Cao W, et al. Smad2 mediates transforming growth factor-beta induction of endothelial nitric oxide synthase expression. Circ Res. 2002;91:806–813
  40. Schachtner SK, Wang Y, Scott BH. Qualitative and quantitative analysis of embryonic pulmonary vessel formation. Am J Respir Cell Mol Biol. 2000;22:157–165
  41. Shaul PW, Afshar S, Gibson LL, Sherman TS, et al. Developmental changes in nitric oxide synthase isoform expression and nitric oxide production in fetal baboon lung. Am J Physiol Lung Cell Mol Physiol. 2002;283:L1192–L1199
  42. Stenmark KR, Abman SH. Lung vascular development: Implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol. 2005;67:623–661
  43. Stenmark KR, Gebb SA. Lung vascular development: Breathing new life into an old problem. Am J Respir Cell Mol Biol. 2003;28:133–137
  44. Vick RN, Owens T, Moise KJ, Chescheir N, et al. Urethral atresia in a neonate with alveolar capillary dysplasia and pulmonary venous misalignment. Urology. 2000;55:774
  45. Wang Y, Nagase S, Koyama A. Stimulatory effect of IGF-I and VEGF on eNOS message, protein expression, eNOS phosphorylation and nitric oxide production in rat glomeruli, and the involvement of PI3-K signaling pathway. Nitric Oxide. 2004;10:25–35
  46. Young SL, Evans K, Eu JP. Nitric oxide modulates branching morphogenesis in fetal rat lung explants. Am J Physiol Lung Cell Mol Physiol. 2002;282:L379–L385
  47. Zhao YD, Courtman DW, Deng Y, et al. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: Efficacy of combined cell and eNOS gene therapy in established disease. Circ Res. 2005;96:442–450
  48. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest. 1997;99:2625–2634

PII: S1050-1738(05)00218-5

doi: 10.1016/j.tcm.2005.11.004

Trends in Cardiovascular Medicine
Volume 16, Issue 1 , Pages 29-34 , January 2006

Article Tools

* Image Usage & Resolution